Semaglutide
Semaglutide — GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives sustained fat loss.
- Activates hypothalamic GLP-1R — reduces hunger signals at the source
- Slows gastric emptying — extends satiety between meals
- Improves insulin sensitivity and fasting glucose regulation
- Clinically demonstrated 15-17% body weight reduction over 68 weeks
- Weekly injection — high compliance compared to daily compounds
Why people research Semaglutide
These are the specific situations and goals that lead researchers to Semaglutide. For research purposes only.
Dosage Calculator
Reference dosing by experience level. For research use only — always consult a licensed healthcare provider.
⚠ For research reference only. Semaglutide is not approved for human use. Always consult a qualified healthcare professional.
What's in the Box
Every Poptides order arrives in premium packaging, ready to use.
Semaglutide Vial
Your selected amount of lyophilized Semaglutide in a sealed, sterile glass vial with silver crimp cap. COA included on request.
BAC Water 3mL
Bacteriostatic water for reconstitution, included with every injectable peptide order. Maintains sterility for multi-dose use.
Syringe Kit
5 × insulin syringes with orange caps, individually sealed, in a dedicated Poptides-branded box.
Research Guide Card + Thank You Note
A QR code card linking to your product's research guide, plus a personal thank you note from the Poptides team.
Discreet Outer Packaging
All orders ship in plain, unmarked outer packaging with no reference to Poptides on the exterior.
How Semaglutide Works
The mechanism of action, step by step.
GLP-1 Receptor Activation
Semaglutide binds and activates GLP-1 receptors in the hypothalamus and brainstem, directly suppressing appetite-driving neurons and increasing satiety signalling.
Gastric Emptying Delay
By slowing the rate at which food leaves the stomach, semaglutide extends the feeling of fullness, reducing overall caloric intake without conscious restriction.
Insulin Secretion Enhancement
Semaglutide potentiates glucose-dependent insulin release from pancreatic beta cells, improving postprandial glucose control without hypoglycaemia risk.
Central Reward Pathway Modulation
GLP-1R activation in mesolimbic brain regions reduces food cue reactivity and cravings, making adherence to caloric targets significantly easier.
Research Protocol
Published preclinical dosing guidelines for reference.
The Science Behind It
Peer-reviewed research supporting the mechanism of Semaglutide.
Semaglutide 2.4 mg vs placebo in adults with overweight or obesity (STEP 1)
Participants receiving semaglutide 2.4 mg weekly achieved a mean weight reduction of 14.9% at 68 weeks, versus 2.4% with placebo, with significant improvements in cardiometabolic risk factors.
New England Journal of Medicine, 2021Cardiovascular outcomes with semaglutide in type 2 diabetes (SUSTAIN-6)
Semaglutide reduced the incidence of major adverse cardiovascular events by 26% versus placebo in high-risk patients with type 2 diabetes over 104 weeks.
New England Journal of Medicine, 2016Once-weekly semaglutide in adults with overweight (STEP 5)
Long-term treatment with semaglutide 2.4 mg demonstrated sustained weight loss of 15.2% at 104 weeks, confirming durability of effect beyond standard clinical trial windows.
Nature Medicine, 2022Customer Reviews
Verified purchases from Canadian customers.
Life-changing for appetite control
After years of yo-yo dieting I finally feel like the hunger is manageable. Down 22 lbs in 4 months with minimal side effects once I was past the first few weeks.
Smooth titration, great results
Started at 0.25 and worked up over 3 months. No major nausea at the lower doses. Sitting at 1 mg now and the results speak for themselves.
Takes patience but worth it
First 2 weeks were rough on the stomach but that settled. Now at month 3 and down 14 lbs. Would recommend going slow on the titration.
Frequently Asked Questions
You May Also Like
Semaglutide